Ms Michele Tait:

The recommendation was on linking the notifiable disease notifications of hepatitis C to the treatment registry, which is a separate entity of the HSE's that tracks any patient who has been prescribed the new drugs. This would link the notification of a patient's diagnosis to the patient's treatment. Those data are not linked currently, but we are considering how such linkages may be developed.